The Journal of Practical Medicine ›› 2026, Vol. 42 ›› Issue (12): 2216-2222.doi: 10.3969/j.issn.1006-5725.2026.12.017
• Chronic Disease Control • Previous Articles
Wenhao SUN,Guangming YAO,Liang LI,Miao YU,Guang WANG,Jiwei ZHANG(
)
Received:2026-03-10
Online:2026-06-25
Published:2026-06-30
Contact:
Jiwei ZHANG
E-mail:zjwyisheng@163.com
CLC Number:
Wenhao SUN,Guangming YAO,Liang LI,Miao YU,Guang WANG,Jiwei ZHANG. The effect of intravenous thrombolysis with alteplase on the levels of 5-HT/5-HIAA, DOPAC/HVA, BDNF and NGF in patients with acute ischemic stroke before endovascular treatment[J]. The Journal of Practical Medicine, 2026, 42(12): 2216-2222.
Tab.1
Comparison of general data between the two groups"
| 项目 | 对照组(n = 87) | 研究组(n = 87) | χ2 /t值 | P值 |
|---|---|---|---|---|
| 性别/[例(%)] | ||||
| 男 | 45(51.72) | 47(54.02) | 0.092 | 0.761 |
| 女 | 42(48.28) | 40(45.98) | ||
| 年龄(x ± s)/岁 | 58.44 ± 6.15 | 59.78 ± 6.22 | 1.429 | 0.155 |
| 发病至入院接受治疗时间(x ± s)/h | 3.09 ± 0.38 | 3.12 ± 0.45 | 0.475 | 0.635 |
| 体质量指数(x ± s)/(kg/m2) | 23.37 ± 1.15 | 23.41 ± 1.19 | 0.225 | 0.822 |
| 闭塞部位/[例(%)] | ||||
| 颈内动脉 | 26(29.89) | 24(27.59) | 0.120 | 0.942 |
| 大脑中动脉M1段 | 44(50.57) | 45(51.72) | ||
| 大脑中动脉M2段 | 17(19.54) | 18(20.69) |
Tab.3
Comparison of neurological deficits, cognitive function and activities of daily living between the two groups"
| 项目 | 对照组 (n = 87) | 研究组 (n = 87) | t值 | P值 |
|---|---|---|---|---|
| NIHSS | ||||
| 治疗前 | 16.89 ± 2.77 | 17.23 ± 3.34 | 0.731 | 0.466 |
| 治疗后3个月 | 8.94 ± 2.15* | 6.69 ± 1.68* | 7.692 | < 0.001 |
| MMSE | ||||
| 治疗前 | 23.74 ± 1.90 | 23.67 ± 1.88 | 0.244 | 0.807 |
| 治疗后3个月 | 25.51 ± 1.10* | 26.03 ± 1.15* | 3.048 | 0.003 |
| MBI | ||||
| 治疗前 | 59.02 ± 3.52 | 58.76 ± 3.44 | 0.493 | 0.623 |
| 治疗后3个月 | 75.42 ± 4.26* | 79.34 ± 5.33* | 5.359 | < 0.001 |
Tab.4
Comparison of cerebral hemodynamics between the two groups (x ± s)/(cm/s)"
| 项目 | 对照组 (n=87) | 研究组 (n=87) | t值 | P值 |
|---|---|---|---|---|
| PSV | ||||
| 治疗前 | 80.22 ± 9.09 | 79.67 ± 8.82 | 0.405 | 0.686 |
| 治疗后3个月 | 104.93 ± 10.77* | 110.34 ± 13.45* | 2.929 | 0.004 |
| EDV | ||||
| 治疗前 | 25.12 ± 3.57 | 24.94 ± 3.45 | 0.338 | 0.736 |
| 治疗后3个月 | 33.61 ± 5.03* | 38.54 ± 6.71* | 5.483 | < 0.001 |
| Vm | ||||
| 治疗前 | 48.15 ± 6.01 | 47.22 ± 5.58 | 1.058 | 0.292 |
| 治疗后3个月 | 62.13 ± 6.21* | 66.54 ± 7.78* | 4.132 | < 0.001 |
Tab.5
Comparison of inflammation-related indicators between the two groups"
| 项目 | 对照组 (n = 87) | 研究组 (n = 87) | t值 | P值 |
|---|---|---|---|---|
| Lp-PLA2/(ng/mL) | ||||
| 治疗前 | 272.38 ± 35.22 | 275.45 ± 37.94 | 0.553 | 0.581 |
| 治疗后3个月 | 202.33 ± 20.41* | 179.76 ± 25.88* | 6.387 | < 0.001 |
| MMP-9/(ng/mL) | ||||
| 治疗前 | 311.89 ± 39.78 | 313.56 ± 42.56 | 0.267 | 0.789 |
| 治疗后3个月 | 221.79 ± 31.25* | 209.77 ± 26.55* | 2.734 | 0.007 |
| hs-CRP/(mg/L) | ||||
| 治疗前 | 15.84 ± 1.25 | 16.05 ± 2.33 | 0.741 | 0.460 |
| 治疗后3个月 | 8.39 ± 1.95* | 7.61 ± 1.56* | 2.913 | 0.004 |
| TNF-α/(pg/mL) | ||||
| 治疗前 | 44.94 ± 6.69 | 45.21 ± 7.78 | 0.245 | 0.806 |
| 治疗后3个月 | 25.82 ± 5.07* | 23.56 ± 4.23* | 3.193 | 0.002 |
Tab.6
Comparison of serum 5-HT / 5-HIAA, DOPAC/ HVA, BDNF and NGF levels between the two groups x ± s"
| 项目 | 对照组 (n = 87) | 研究组 (n = 87) | t值 | P值 |
|---|---|---|---|---|
| 5-HT/5-HIAA | ||||
| 治疗前 | 1.15 ± 0.36 | 1.13 ± 0.34 | 0.377 | 0.707 |
| 治疗后3个月 | 1.41 ± 0.40* | 1.69 ± 0.51* | 4.029 | < 0.001 |
| DOPAC/HVA | ||||
| 治疗前 | 0.75 ± 0.22 | 0.72 ± 0.13 | 1.095 | 0.275 |
| 治疗后3个月 | 1.14 ± 0.35* | 1.45 ± 0.41* | 5.346 | < 0.001 |
| BDNF/(ng/mL) | ||||
| 治疗前 | 18.09 ± 3.34 | 17.83 ± 3.21 | 0.524 | 0.601 |
| 治疗后3个月 | 22.19 ± 4.47* | 24.32 ± 5.54* | 2.791 | 0.006 |
| NGF/(pg/mL) | ||||
| 治疗前 | 181.23 ± 25.44 | 179.87 ± 26.78 | 0.343 | 0.732 |
| 治疗后3个月 | 221.76 ± 33.12* | 238.89 ± 37.68* | 3.185 | 0.002 |
| [1] |
姜浩,程凯理,陈柳. 血清血小板反应蛋白-1联合阿尔伯塔中风项目早期CT评分对大动脉闭塞性急性脑梗死患者预后的评估价值[J]. 实用医学杂志, 2025, 41(16): 2561-2567. doi: 10.3969/j.issn.1006-5725.2025.16.018 .
doi: 10.3969/j.issn.1006-5725.2025.16.018 |
| [2] |
LIU C, GUO C, LI F, et al. Intra-arterial urokinase after endovascular reperfusion for acute ischemic stroke: The post-uk randomized clinical trial[J]. JAMA, 2025, 333(7): 589-598. doi: 10.1001/jama.2024.23480 .
doi: 10.1001/jama.2024.23480 |
| [3] |
HUANG J, YANG J, LIU C, et al. Intra-arterial tenecteplase following endovascular reperfusion for large vessel occlusion acute ischemic stroke: The post-tnk randomized clinical trial[J]. JAMA, 2025, 333(7): 579-588. doi: 10.1001/jama.2024.23466 .
doi: 10.1001/jama.2024.23466 |
| [4] |
李圆圆,杨杨,李万春,等. 大血管闭塞性急性缺血性卒中患者血管内治疗术后预后不良预测模型的构建及价值分析[J]. 南京医科大学学报(自然科学版), 2026, 46(1): 68-76. doi: 10.7655/NYDXBNSN250948 .
doi: 10.7655/NYDXBNSN250948 |
| [5] |
CHATTERJEE M, SAHA S, SINHA S, et al. A three-pronged analysis confirms the association of the serotoninergic system with attention deficit hyperactivity disorder[J]. World J Pediatr, 2022, 18(12): 825-834. doi: 10.1007/s12519-022-00614-5 .
doi: 10.1007/s12519-022-00614-5 |
| [6] |
LI W, LI W, WEN Y, et al. Repetitive transcranial magnetic stimulation elevates the serum levels of neurotrophic factors and serotonin and its metabolites in patients with ischemic stroke[J]. Front Neurol, 2025, 16(1): 1513131. doi: 10.3389/fneur.2025. 1513131 .
doi: 10.3389/fneur.2025. 1513131 |
| [7] |
SUN L, DOU X, YANG W. Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage[J]. Folia Morphol (Warsz), 2023, 82(2): 248-255. doi: 10.5603/FM.a2022.0027 .
doi: 10.5603/FM.a2022.0027 |
| [8] |
WANG D X, HUANG W T, SHI J F, et al. Fgf21, a modulator of astrocyte reactivity, protects against ischemic brain injury through anti-inflammatory and neurotrophic pathways[J]. Acta Pharmacol Sin, 2025, 46(7): 1834-1851. doi: 10.1038/s41401-024-01462-x .
doi: 10.1038/s41401-024-01462-x |
| [9] |
KHODJIEVA D T, AKHROROVA S B, KHAYRIEVA M F, et al. Correlation between neuroimaging, neurological deficits, and neurotrophic proteins in predicting rehabilitation potential in ischemic stroke patients[J]. Quant Imaging Med Surg, 2025, 15(10): 10123-10138. doi: 10.21037/qims-24-2231 .
doi: 10.21037/qims-24-2231 |
| [10] |
李丽,喻伟. 阿替普酶联合尤瑞克林对急性脑梗死的疗效及对脑血管储备功能影响[J]. 中国临床药理学杂志, 2021, 37(24): 3307-3310. doi: 10.13699/j.cnki.1001-6821.2021.24.001 .
doi: 10.13699/j.cnki.1001-6821.2021.24.001 |
| [11] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性卒中诊治指南2023[J]. 中华神经科杂志, 2024, 57(6): 523-559. doi: 10.3760/cma.j.cn113694-20240410-00221 .
doi: 10.3760/cma.j.cn113694-20240410-00221 |
| [12] |
LIU Y, YU Y, OUYANG J, et al. Functional outcome prediction in acute ischemic stroke using a fused imaging and clinical deep learning model[J]. Stroke, 2023, 54(9): 2316-2327. doi: 10.1161/STROKEAHA.123.044072 .
doi: 10.1161/STROKEAHA.123.044072 |
| [13] |
YU Y, ZHANG Y, ZHU C, et al. Remnant cholesterol inflammatory index, calculated from residual cholesterol to c-reactive protein ratio, and stroke outcomes: A retrospective study using the national institutes of health stroke scale and modified rankin scale[J]. Lipids Health Dis, 2025, 24(1): 228-228. doi: 10.1186/s12944-025-02650-2 .
doi: 10.1186/s12944-025-02650-2 |
| [14] |
BAI X, ZHANG X, GONG H, et al. Different types of percutaneous endovascular interventions for acute ischemic stroke[J]. Cochrane Database Syst Rev, 2023, 5(5): 14676-14676. doi: 10.1002/14651858.CD014676.pub2 .
doi: 10.1002/14651858.CD014676.pub2 |
| [15] |
WANG Z, ZHANG K, ZHONG C, et al. Plasma Human cartilage glycoprotein-39 and cognitive impairment after acute ischemic stroke[J]. J Am Heart Assoc, 2025, 14(2): 36790-36790. doi: 10.1161/JAHA.124.036790 .
doi: 10.1161/JAHA.124.036790 |
| [16] |
TALAVERA B, GÓMEZ-VICENTE B, MARTÍNEZ-GALDÁMEZ M, et al. Delayed neurological improvement after full endovascular reperfusion in acute anterior circulation ischemic stroke[J]. Stroke, 2021, 52(7): 2210-2217. doi: 10.1161/STROKEAHA.120.032066 .
doi: 10.1161/STROKEAHA.120.032066 |
| [17] |
LIU C, SUI H, LI Z, et al. Thbs1 in macrophage-derived exosomes exacerbates cerebral ischemia-reperfusion injury by inducing ferroptosis in endothelial cells[J]. J Neuroinflammation, 2025, 22(1): 48-48. doi: 10.1186/s12974-025-03382-x .
doi: 10.1186/s12974-025-03382-x |
| [18] |
刘荣毅,温昌明,孙军,等. 发病4.5小时内急性基底动脉闭塞性卒中行桥接治疗与直接取栓的有效性和安全性分析[J]. 中国脑血管病杂志, 2025, 22(3): 145-156. doi: 10.3969/j.issn.1672-5921.2025.03.001 .
doi: 10.3969/j.issn.1672-5921.2025.03.001 |
| [19] |
REGENHARDT R W, POTTER C A, HUANG S S, et al. Advanced imaging for acute stroke treatment selection: Ct, cta, ct perfusion, and mr imaging[J]. Radiol Clin North Am, 2023, 61(3): 445-456. doi: 10.1016/j.rcl.2023.01.003 .
doi: 10.1016/j.rcl.2023.01.003 |
| [20] |
LIU J, LI X, QU J. Risk factors for acute ischemic stroke in patients with type 2 diabetes mellitus[J]. Medicine (Baltimore), 2023, 102(47): 36114-36114. doi: 10.1097/MD.0000000000036114 .
doi: 10.1097/MD.0000000000036114 |
| [21] |
SHASHIDHARA K C, PADAMATI A R, MANTHAPPA M, et al. Clinical and radiological evaluation of severity of acute ischemic stroke with special reference to neuroinflammatory biomarkers[J]. Ann Afr Med, 2025, 24(3): 567-572. doi: 10.4103/aam.aam_78_24 .
doi: 10.4103/aam.aam_78_24 |
| [22] |
CUI P, LU W, WANG J, et al. Microglia/macrophages require vitamin D signaling to restrain neuroinflammation and brain injury in a murine ischemic stroke model[J]. J Neuroinflammation, 2023, 20(1): 63-63. doi: 10.1186/s12974-023-02705-0 .
doi: 10.1186/s12974-023-02705-0 |
| [23] |
ZHAO T, LIU T, WANG L, et al. Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients[J]. J Affect Disord, 2024, 349(1): 332-341. doi: 10.1016/j.jad.2024.01.023 .
doi: 10.1016/j.jad.2024.01.023 |
| [24] |
WEI R, ZHANG L, HU W, et al. Zeb2/axin2-enriched bmsc-derived exosomes promote post-stroke functional recovery by enhancing neurogenesis and neural plasticity[J]. J Mol Neurosci, 2022, 72(1): 69-81. doi: 10.1007/s12031-021-01887-7 .
doi: 10.1007/s12031-021-01887-7 |
| [25] |
ZHOU Y, HE Y, CAMPBELL B C V, et al. Alteplase for acute ischemic stroke at 4.5 to 24 hours: The hope randomized clinical trial[J]. JAMA, 2025, 334(9): 788-797. doi: 10.1001/jama. 2025.12063 .
doi: 10.1001/jama. 2025.12063 |
| [26] |
XIONG Y, CAMPBELL B C V, SCHWAMM L H, et al. Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy[J]. N Engl J Med, 2024, 391(3): 203-212. doi: 10.1056/NEJMoa2402980 .
doi: 10.1056/NEJMoa2402980 |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||

